Metformin increases mitochondrial energy formation in L6 muscle cell cultures

Journal of Biological Chemistry

Volumn 288, Issue 28, 2013, Pages 20369-20377

  Vytla, Veeravenkata S ^a,b   Ochs, Raymond S ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CHROMIUM COMPOUNDS; FATTY ACIDS; MITOCHONDRIA; MUSCLE; RECOVERY;

DINITROPHENOLS; ENERGY FORMATION; ENERGY INTERRUPTION; FATTY ACID OXIDATION; GLUCONEOGENESIS; LOW CONCENTRATIONS; MITOCHONDRIAL ENERGY; MITOCHONDRIAL RESPIRATION;

MOLECULAR BIOLOGY;

2,4 DINITROPHENOL; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; AZIDE; CREATINE PHOSPHATE; METFORMIN; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CELL ENERGY; CELL LINE; CELL STRAIN L6; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; IN VIVO STUDY; MITOCHONDRIAL ENERGY FORMATION; MUSCLE FIBER CULTURE; NONHUMAN; PRIORITY JOURNAL;

EID: 84880054521     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.482646     Document Type: Article

References (59)

1. Ben Sahra, I., Laurent, K., Giuliano, S., Larbret, F., Ponzio, G., Gounon, P., Le Marchand-Brustel, Y., Giorgetti-Peraldi, S., Cormont, M., Bertolotto, C., Deckert, M., Auberger, P., Tanti, J. F., and Bost, F. (2010) Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res. 70, 2465-2475
2. Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., and Fürnsinn, C. (2004) Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53, 1052-1059 (Pubitemid 38436618)
3. Carvalho, C., Correia, S., Santos, M. S., Seiça, R., Oliveira, C. R., and Moreira, P. I. (2008) Metformin promotes isolated rat liver mitochondria impairment. Mol. Cell. Biochem. 308, 75-83 (Pubitemid 351167847)
4. El-Mir, M. Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., and Leverve, X. (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275, 223-228 (Pubitemid 30038975)
5. Owen, M. R., Doran, E., and Halestrap, A. P. (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614 (Pubitemid 30410251)
6. Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., and Hardie, D. G. (2010) Use of cells expressing γ subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 11, 554-565
7. Bailey, C. J. (1992) Biguanides and NIDDM. Diabetes Care 15, 755-772
8. Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., and Klip, A. (1992) Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131, 1165-1173
9. Klip, A., Gumà, A., Ramlal, T., Bilan, P. J., Lam, L., and Leiter, L. A. (1992) Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology 130, 2535-2544
10. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174 (Pubitemid 32995375)
11. Guigas, B., Detaille, D., Chauvin, C., Batandier, C., De Oliveira, F., Fontaine, E., and Leverve, X. (2004) Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem. J. 382, 877-884 (Pubitemid 39312902)
12. Hoek, J. B. (2006) Metformin and the fate of fat. Gastroenterology 130, 2234-2237
13. Hoek, J. B. (2006) Author reply. Gastroenterology 131, 974-975
14. Hardie, D. G. (2006) Neither LKB1 nor AMPK are the direct targets of metformin. Gastroenterology 131, 973-975
15. Silva, F. M., da Silva, M. H., Bracht, A., Eller, G. J., Constantin, R. P., and Yamamoto, N. S. (2010) Effects of metformin on glucose metabolism of perfused rat livers. Mol. Cell. Biochem. 340, 283-289
16. Ouyang, J., Parakhia, R. A., and Ochs, R. S. (2011) Metformin activates AMP kinase through inhibition of AMP deaminase. J. Biol. Chem. 286, 1-11
17. Misra, P. (2008) AMP activated protein kinase: a next generation target for total metabolic control. Expert Opin. Ther. Targets 12, 91-100
18. Blei, M. L., Conley, K. E., and Kushmerick, M. J. (1993) Separate measures of ATP utilization and recovery in human skeletal muscle. J. Physiol. 465, 203-222 (Pubitemid 23201393)
19. Haseler, L. J., Hogan, M. C., and Richardson, R. S. (1999) Skeletal muscle phosphocreatine recovery in exercise-trained humans is dependent on O2 availability. J. Appl. Physiol. 86, 2013-2018 (Pubitemid 29275578)
20. He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., and Wondisford, F. E. (2009) Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Cell 137, 635-646
21. Caton, P. W., Nayuni, N. K., Kieswich, J., Khan, N. Q., Yaqoob, M. M., and Corder, R. (2010) Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J. Endocrinol. 205, 97-106
22. Ronner, P., Friel, E., Czerniawski, K., and Fränkle, S. (1999) Luminometric assays of ATP, phosphocreatine, and creatine for estimation of free ADP and free AMP. Anal. Biochem. 275, 208-216
23. Ochs, R. S., and Harris, R. A. (1978) Studies on the relationship between glycolysis, lipogenesis, gluconeogenesis, and pyruvate kinase activity of rat and chicken hepatocytes. Arch. Biochem. Biophys. 190, 193-201 (Pubitemid 9009703)
24. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85 (Pubitemid 16258399)
25. Berridge, M. V., Herst, P. M., and Tan, A. S. (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu. Rev. 11, 127-152 (Pubitemid 41510276)
26. Calabro, A. R., Konsoula, R., and Barile, F. A. (2008) Evaluation of in vitro cytotoxicity and paracellular permeability of intact monolayers with mouse embryonic stem cells. Toxicol. In Vitro 22, 1273-1284
27. Janjic, D., and Wollheim, C. B. (1992) Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay. Diabetologia 35, 482-485
28. Petty, R. D., Sutherland, L. A., Hunter, E. M., and Cree, I. A. (1995) Comparison of MTT and ATP-based assays for the measurement of viable cell number. J. Biolumin. Chemilumin. 10, 29-34
29. 31P NMR studies using creatine analogs. J. Biol. Chem. 270, 12428-12438
30. Veech, R. L., Lawson, J. W., Cornell, N. W., and Krebs, H. A. (1979) Cytosolic phosphorylation potential. J. Biol. Chem. 254, 6538-6547
31. Pressman, B. C. (1963) The effects of guanidine and alkylguanidines on the energy transfer reactions of mitochondria. J. Biol. Chem. 238, 401-409
32. Schäfer, G., and Bojanowski, D. (1972) Interaction of biguanides with mitochondrial and synthetic membranes. Eur. J. Biochem. 27, 364-375
33. Musi, N. (2006) AMP-activated protein kinase and type 2 diabetes. Curr. Med. Chem. 13, 583-589
34. Misra, P., and Chakrabarti, R. (2007) The role of AMP kinase in diabetes. Indian J. Med. Res. 125, 389-398 (Pubitemid 46805453)
35. Hardie, D. G. (2004) The AMP-activated protein kinase pathway - new players upstream and downstream. J. Cell Sci. 117, 5479-5487
36. Cornell, N. W. (1983) in Isolation, Characterization, and Use of Hepatocytes (Harris, R. A., and Cornell, N. W., eds) pp. 11-20, Elsevier Biomedical, New York
37. Baur, H., Kasperek, S., and Pfaff, E. (1975) Criteria of viability of isolated liver cells. Hoppe-Seyler's Z. Physiol. Chem. 356, 827-838
38. Janjetovic, K., Vucicevic, L., Misirkic, M., Vilimanovich, U., Tovilovic, G., Zogovic, N., Nikolic, Z., Jovanovic, S., Bumbasirevic, V., Trajkovic, V., and Harhaji-Trajkovic, L. (2011) Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt. Eur. J. Pharmacol. 651, 41-50
39. Hardie, D. G., Ross, F. A., and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262
40. Otto, M., Breinholt, J., and Westergaard, N. (2003) Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes. Metab. 5, 189-194 (Pubitemid 36519352)
41. Hawley, S. A., Gadalla, A. E., Olsen, G. S., and Hardie, D. G. (2002) The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420-2425 (Pubitemid 34827390)
42. Walker, J., Jijon, H. B., Diaz, H., Salehi, P., Churchill, T., and Madsen, K. L. (2005) 5-Aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK. Biochem. J. 385, 485-491 (Pubitemid 40173969)
43. Stumvoll, M., Häring, H. U., and Matthaei, S. (2007) Metformin. Endocr. Res. 32, 39-57 (Pubitemid 351411678)
44. Bridger, W. A., and Henderson, J. F. (1983) Cell ATP, Wiley Interscience, John Wiley and Sons, New York
45. Morioka, K., Nakatani, K., Matsumoto, K., Urakawa, H., Kitagawa, N., Katsuki, A., Hori, Y., Gabazza, E. C., Yano, Y., Nishioka, J., Nobori, T., Sumida, Y., and Adachi, Y. (2005) Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells. Int. J. Mol. Med. 15, 449-452
46. Yuan, L., Ziegler, R., and Hamann, A. (2002) Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes. Chin. Med. J. 115, 1843-1848 (Pubitemid 36105064)
47. Zang, M., Zuccollo, A., Hou, X., Nagata, D., Walsh, K., Herscovitz, H., Brecher, P., Ruderman, N. B., and Cohen, R. A. (2004) AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 279, 47898-47905 (Pubitemid 39540941)
48. Suwa, M., Egashira, T., Nakano, H., Sasaki, H., and Kumagai, S. (2006) Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J. Appl. Physiol. 101, 1685-1692 (Pubitemid 44904490)
49. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270
50. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033
51. Lanaspa, M. A., Cicerchi, C., Garcia, G., Li, N., Roncal-Jimenez, C. A., Rivard, C. J., Hunter, B., Andrés-Hernando, A., Ishimoto, T., Sánchez-Lozada, L. G., Thomas, J., Hodges, R. S., Mant, C. T., and Johnson, R. J. (2012) Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PloS One 7, e48801
52. Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., and Viollet, B. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355-2369
53. Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., and Guigas, B. (2011) Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia 54, 3101-3110
54. Buler, M., Aatsinki, S. M., Izzi, V., and Hakkola, J. (2012) Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism. PloS One 7, e49863
55. Bruckbauer, A., and Zemel, M. B. (2013) Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity. Diabetes Metab. Syndr. Obes. 6, 93-102
56. Simmons, A., Meshulam, L. N., and Corkey, B. E. (2013) Metformin relieves oxidative stress and leads to differential modulation of function in key metabolic tissues. FASEB J. 27, LB113
57. Barreto-Torres, G. A., and Javadov, S. (2013) AMP-kinase prevents oxidative stress-induced mitochondrial dysfunction through regulation of protein acetylation in cardiomyocytes. FASEB J. 27, 682.6
58. Koh, H.-J., Toyoda, T., Fujii, N., Jung, M. M., Rathod, A., Middelbeek, R. J., Lessard, S. J., Treebak, J. T., Tsuchihara, K., Esumi, H., Richter, E. A., Wojtaszewski, J. F., Hirshman, M. F., and Goodyear, L. J. (2010) Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 107, 15541-15546
59. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B., and Hue, L. (2006) 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874 (Pubitemid 44100158)